Lutetium177DOTATOCQualityChecker
Lutetium-177 DOTATOC
Utility description: Lutetium-177 DOTATOC
Lutetium-177 DOTATOC Quality Checker — Lutetium-177 DOTATOC for Peptide Receptor Radionuclide Therapy (PRRT) ℹ️ Utility checks critical parameters of Lutetium-177 DOTATOC: • Radionuclidic purity (≥99.9%) • Lutetium-177m impurity (≤0.01%) • Radiochemical purity (≥95%) — binding to DOTATOC • Free lutetium (≤5%) • Precursor peptide (≤10%) • pH, endotoxins, sterility, heavy metals ⚠️ CRITICAL: Free lutetium >5% → accumulation in bone marrow and liver! Lu-177m impurity >0.01% → long-term radiation burden due to 160.4-day half-life! Usage: Lutetium177DOTATOCQualityChecker.exe → demo mode (console output) Lutetium177DOTATOCQualityChecker.exe input.csv output.json → evaluate your data Input format: BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Lutetium177mImpurityPercent,RadiochemicalPurityPercent,FreeLutetiumPercent,PrecursorPeptidePercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType Example (sterility: 0=sterile, 1=contaminated): Lu177-DOTATOC-2026-001,7400.0,99.99,0.005,98.5,1.0,5.0,5.5,40.0,0,2,Therapeutic Supported product types: • Therapeutic — Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumors (NETs) — WHY IS THIS NEEDED? Lutetium-177 DOTATOC is a radiopharmaceutical for targeted therapy of somatostatin receptor-positive tumors: • Lu-177 half-life: 6.65 days — optimal for therapy • Beta radiation (0.497 MeV max) — local destruction of tumor cells • DOTATOC — somatostatin analog, binds to subtype 2 and 5 receptors • Used for gastroenteropancreatic neuroendocrine tumors (GEP-NETs) ⚠️ CRITICAL: • Radiochemical purity ≥95% — Lutetium must be firmly chelated by DOTATOC. Free lutetium accumulates in bones and liver, causing bone marrow toxicity. • Lutetium-177m impurity ≤0.01% — Lu-177m (T½=160.4 days) is a metastable isomer with a long half-life, creating unnecessary long-term radiation burden. • Free lutetium ≤5% — high levels of free lutetium lead to systemic toxicity. • Precursor peptide ≤10% — chemical impurity (unlabeled DOTATOC) can compete for receptors, reducing therapy efficacy. Key features: • Control of radiochemical purity (Lu-177 binding to DOTATOC) • Check for long-lived Lu-177m impurity • Assessment of free lutetium level (risk of myelotoxicity) • Control of chemical purity (precursor peptide) Critical parameters: • Radionuclidic purity: ≥99.9% • Lutetium-177m impurity: ≤0.01% • Radiochemical purity: ≥95.0% • Free lutetium: ≤5.0% • Precursor peptide: ≤10.0% • pH: 4.0–8.0 • Endotoxins: ≤175 EU/vial • Sterility: no microbial growth • Heavy metals: ≤10 ppm 💡 Usage tips: Radiochemical purity is determined by TLC or HPLC Lu-177m is controlled by gamma spectrometry (208 keV and 113 keV peaks for Lu-177, additional peaks for Lu-177m) Free lutetium is determined as the fraction not bound to the peptide The drug is administered intravenously by infusion ⚠️ Note: DOTATOC has high affinity for somatostatin receptor subtype 2. The presence of unlabeled precursor can saturate receptors, reducing the uptake of the radioactive drug by the tumor. Therefore, control of chemical purity is critical for therapeutic doses. Lu-177m is an important quality parameter as its long half-life increases patient radiation dose without therapeutic benefit.
input.csv
BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Lutetium177mImpurityPercent,RadiochemicalPurityPercent,FreeLutetiumPercent,PrecursorPeptidePercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType Lu177-DOTATOC-2026-001,7400.0,99.99,0.005,98.5,1.0,5.0,5.5,40.0,0,2,Therapeutic Lu177-DOTATOC-2026-002,7200.0,99.85,0.02,94.0,6.5,12.0,5.0,180.0,0,8,Therapeutic Lu177-DOTATOC-2026-003,7500.0,99.95,0.008,99.0,0.5,2.0,6.0,20.0,0,1,Therapeutic
URS & FS — User Requirements and Functional Specification
This document describes the controlled interface and behaviour of Lutetium177DOTATOCQualityChecker for Lutetium-177 DOTATOC.
Domain limits and critical parameters
- ℹ️ Utility checks critical parameters of Lutetium-177 DOTATOC:
- • Radionuclidic purity (≥99.9%)
- • Lutetium-177m impurity (≤0.01%)
- • Radiochemical purity (≥95%) — binding to DOTATOC
- • Free lutetium (≤5%)
- • Precursor peptide (≤10%)
- • pH, endotoxins, sterility, heavy metals
- ⚠️ CRITICAL: Free lutetium >5% → accumulation in bone marrow and liver!
- Lu-177m impurity >0.01% → long-term radiation burden due to 160.4-day half-life!
- BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Lutetium177mImpurityPercent,RadiochemicalPurityPercent,FreeLutetiumPercent,PrecursorPeptidePercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType
- Example (sterility: 0=sterile, 1=contaminated):
- ⚠️ CRITICAL:
- • Radiochemical purity ≥95% — Lutetium must be firmly chelated by DOTATOC. Free lutetium accumulates in bones and liver, causing bone marrow toxicity.
- • Lutetium-177m impurity ≤0.01% — Lu-177m (T½=160.4 days) is a metastable isomer with a long half-life, creating unnecessary long-term radiation burden.
URS — User Requirements Specification
| ID | Requirement | Criticality | Acceptance criterion |
|---|---|---|---|
| URS-001 | The utility shall accept an input.csv file with the exact headers defined in the data contract. | High | The file is processed without manual header editing. |
| URS-002 | The utility shall perform deterministic QC evaluation for Lutetium-177 DOTATOC using input values, approved limits and domain rules. | High | Each input row receives a PASS / WARNING / FAIL status. |
| URS-003 | The utility shall validate mandatory fields, data types, numeric ranges, units and pharmaceutical/radiochemical plausibility. | High | Schema and conversion errors are explicitly reported. |
| URS-004 | The utility shall identify critical deviations related to radionuclidic purity, radiochemical purity, free radionuclide, impurities, pH, endotoxins and sterility when such fields are present. | High | A critical deviation causes FAIL or a separate critical finding. |
| URS-005 | The utility shall generate output.json with machine-readable results, source values, warnings and failures. | High | JSON is suitable for LIMS/ELN/MES integration and QA/QC review. |
| URS-006 | The utility shall not use machine learning to decide conformance. | Medium | The result is based on explicit rules, thresholds and input values. |
| URS-007 | The utility shall preserve traceability between batch number, input values, applied rules and final status. | High | The output contains the batch identifier and the list of checked parameters. |
| URS-008 | The documentation shall support IQ/OQ preparation and inspection discussion with FDA/EMA/Roszdravnadzor or local regulators. | Medium | URS & FS, input.csv/output.json contract and test scenarios are supplied with the utility. |
input.csv contract
| # | Field | Type | Sample | Purpose |
|---|---|---|---|---|
| 1 | BatchNumber | string | Lu177-DOTATOC-2026-001 | Batch or lot identifier used for traceability. |
| 2 | TotalActivityMBq | decimal | 7400.0 | Radioactivity value used for release, decay or dose-related assessment. |
| 3 | RadionuclidicPurityPercent | string | 99.99 | Radionuclidic purity; a critical radiation-safety and impurity parameter. |
| 4 | Lutetium177mImpurityPercent | string | 0.005 | Controlled impurity or residual material. |
| 5 | RadiochemicalPurityPercent | string | 98.5 | Radiochemical purity; confirms the labelled chemical form and binding quality. |
| 6 | FreeLutetiumPercent | decimal | 1.0 | Free radionuclide / unbound species; important for non-target uptake and toxicity. |
| 7 | PrecursorPeptidePercent | string | 5.0 | Controlled input parameter used by the deterministic QC rules. |
| 8 | pH | decimal | 5.5 | Solution pH; relevant for stability, compatibility and administration. |
| 9 | EndotoxinsEU | decimal | 40.0 | Bacterial endotoxins; critical for parenteral administration. |
| 10 | SterilityTest | flag / boolean | 0 | Sterility result; critical release parameter. |
| 11 | HeavyMetalsPPM | decimal | 2 | Elemental impurity / metal residue parameter. |
| 12 | ProductType | string | Therapeutic | Controlled input parameter used by the deterministic QC rules. |
BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Lutetium177mImpurityPercent,RadiochemicalPurityPercent,FreeLutetiumPercent,PrecursorPeptidePercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType Lu177-DOTATOC-2026-001,7400.0,99.99,0.005,98.5,1.0,5.0,5.5,40.0,0,2,Therapeutic Lu177-DOTATOC-2026-002,7200.0,99.85,0.02,94.0,6.5,12.0,5.0,180.0,0,8,Therapeutic Lu177-DOTATOC-2026-003,7500.0,99.95,0.008,99.0,0.5,2.0,6.0,20.0,0,1,Therapeutic
FS — Functional Specification
| ID | Function | Implementation |
|---|---|---|
| FS-001 | CSV import | Read input.csv in UTF-8/CSV-compatible format and validate the header and expected columns. |
| FS-002 | Schema validation | Check mandatory fields and column count; report unknown or missing key fields. |
| FS-003 | Type conversion | Convert numeric, flag and text values; invalid formats are recorded as row-level errors. |
| FS-004 | Domain rule engine | Apply domain rules for Lutetium-177 DOTATOC, including critical limits from the utility description and approved specification. |
| FS-005 | Status aggregation | Produce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance. |
| FS-006 | JSON export | Write output.json with detailed checks, source values, warnings, failures and critical findings. |
| FS-007 | Audit support | Keep the result structure suitable for review, deviation investigation, calculation reproduction and IQ/OQ preparation. |
| FS-008 | Integration contract | Support the production scenario: LIMS/ELN/MES creates input.csv, the utility returns output.json, the portal displays description and documentation. |
Example output.json
{
"utilityId": "lutetium177-dotatoc-quality-checker",
"api": "Lutetium-177 DOTATOC",
"overallStatus": "PASS|WARNING|FAIL",
"sourceFile": "input.csv",
"checks": [
{
"parameter": "BatchNumber",
"value": "Lu177-DOTATOC-2026-001",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "TotalActivityMBq",
"value": "7400.0",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "RadionuclidicPurityPercent",
"value": "99.99",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Lutetium177mImpurityPercent",
"value": "0.005",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "RadiochemicalPurityPercent",
"value": "98.5",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "FreeLutetiumPercent",
"value": "1.0",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "PrecursorPeptidePercent",
"value": "5.0",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "pH",
"value": "5.5",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
}
],
"criticalFindings": []
}
OQ/PQ test scenarios
| ID | Scenario | Expected result |
|---|---|---|
| OQ-001 | Valid sample row | PASS or acceptable WARNING according to the rules. |
| OQ-002 | Mandatory column missing | Schema error or FAIL. |
| OQ-003 | Non-numeric value in numeric field | Type-conversion error. |
| OQ-004 | Critical parameter outside limit | FAIL and critical finding. |
| PQ-001 | User real batch/lot | Reviewed result with input.csv and output.json retained. |
QA/QC and change control
- Do not rename columns without updating the validator and test set.
- Retain
input.csv,output.json, executable version and checksum. - Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
- Critical radiopharmaceutical limits must be verified against the approved specification and local SOPs.
Included in packages
Endocrinology QC Suite
QC package for endocrinology: thyroid, pituitary/peptide hormones, corticosteroids, sex hormones and selected metabolic medicines.
OpenGastroenterology QC Suite
QC package for gastroenterology: PPIs, antiemetics, prokinetics, IBD medicines, laxatives, enzymes and GI anti-infectives.
OpenNeurology QC Suite
QC package for neurology and neuropsychiatry: antiepileptics, antiparkinsonian medicines, antidepressants, antipsychotics, analgesics and neurological diagnostic radiopharmaceuticals.
OpenPetRad3: expanded PET/SPECT and radiopharmaceutical QC package
A curated suite for PET/SPECT radiopharmaceuticals, generator and cyclotron radionuclides, labelled compounds, radiochemical purity, breakthrough, sterility and endotoxin control.
OpenRadiology QC Suite
QC package for radiology and diagnostic imaging: radiopharmaceuticals, PET/SPECT, contrast media, iodinated and gadolinium products, plus particle, sterility and endotoxin checks.
OpenRPH isotope family: beta-emitting therapy
Lu-177, Y-90, Ho-166, Re-188, Sm-153, Sr-89, P-32, Cu-67 and Tb-161.
OpenRPH organ/system: bone and musculoskeletal
Bone scintigraphy, MDP/PYP, marrow, bone-pain palliation, skeletal metastases and radiosynovectomy.
OpenRPH organ/system: brain and CNS
Brain perfusion, dopamine transporter, amyloid/tau, receptor imaging and neurological SPECT/PET.
OpenRPH organ/system: endocrine, thyroid and NET
Radioiodine, thyroid/parathyroid, somatostatin receptor, MIBG and neuroendocrine workflows.
OpenRPH organ/system: hepatobiliary and GI
HIDA, mebrofenin, gallbladder, gastric emptying, GI transit, bleeding and liver/spleen imaging.
OpenRPH organ/system: oncology and theranostics
Tumour imaging, PSMA/FAPI/receptor tracers, immuno-PET, targeted radionuclide therapy and radioembolization.
OpenRPH use case: radionuclide therapy and theranostics
Lu-177, Ac-225, Ra-223, Y-90, Ho-166, Sm-153, Sr-89, Re-188, Tb-161, I-131 and other therapeutic radiopharmaceuticals: activity, purity, free metal, daughters and toxicological constraints.
OpenRPH workflow: generators and isotope purity
Generator eluate, breakthrough, radionuclidic purity, isotope mix and starting radionuclides.
OpenRPH workflow: imaging QC and quantitative interpretation
Acquisition, uptake, clearance, perfusion, transit, ejection fraction, segmentation and quantitative imaging.
OpenRPH workflow: product release QC
Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.
OpenRPH workflow: synthesis, labelling and kit reconstitution
Radiolabelling, synthesis, chelation, reducing agent, pH/stoichiometry and kit preparation.
OpenRPH: combined radiopharmaceutical QC package
RPH combines PetRad, PetRad2 and PetRad3 into one umbrella package for PET/SPECT, therapeutic radionuclides, generators, labelled compounds, decay calculations, sterility, endotoxins and radiochemical/radionuclidic purity.
Open